Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
作者信息
Rubio Jose M, Kane John M
机构信息
The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA.
Hofstra Northwell School of Medicine, Hempstead, NY, USA.
出版信息
NPJ Schizophr. 2017 Oct 11;3(1):36. doi: 10.1038/s41537-017-0039-z.
Abstract
摘要
相似文献
1
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?抗精神病维持治疗药物引发的精神病突破（BAMM）：我们能学到什么？
NPJ Schizophr. 2017 Oct 11;3(1):36. doi: 10.1038/s41537-017-0039-z.
2
Breakthrough psychosis under antipsychotic maintenance treatment and social stress.抗精神病药物维持治疗及社会压力下的突破性精神病
Psychol Med. 2019 Dec;49(16):2808-2809. doi: 10.1017/S003329171900206X. Epub 2019 Aug 29.
3
Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.在开始抗精神病药物治疗3周内首发精神病患者早期纹状体肥大。
Psychol Med. 2009 May;39(5):793-800. doi: 10.1017/S0033291708004212. Epub 2008 Aug 20.
4
Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.首发精神病后停用抗精神病药物后复发的比率和预测因素。
Schizophr Res. 2018 May;195:231-236. doi: 10.1016/j.schres.2017.10.030. Epub 2017 Oct 21.
5
Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.分期治疗和早期精神病研究中的可接受性指南 (STAGES)：一项针对首发精神病且自我伤害或攻击风险低的患者的随机安慰剂对照试验，比较强化心理社会治疗加或不加抗精神病药物治疗的效果。研究方案和参与者的基线特征。
Early Interv Psychiatry. 2019 Aug;13(4):953-960. doi: 10.1111/eip.12716. Epub 2018 Jul 19.
6
Psychosis patients' knowledge, adherence and attitudes towards the naming of antipsychotic medication in Hong Kong.香港精神病患者对抗精神病药物命名的认知、依从性及态度。
Early Interv Psychiatry. 2015 Oct;9(5):422-7. doi: 10.1111/eip.12169. Epub 2014 Sep 20.
7
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.抗精神病药剂量减少能否促进首发精神病患者更好的功能恢复？一项抗精神病药剂量减少的随机对照试验。减少试验：研究方案。
Early Interv Psychiatry. 2019 Dec;13(6):1345-1356. doi: 10.1111/eip.12769. Epub 2018 Nov 29.
8
What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis.服用抗精神病药物是怎样的体验？一项针对首发精神病患者的定性研究。
J Psychiatr Ment Health Nurs. 2016 Mar;23(2):108-15. doi: 10.1111/jpm.12288.
9
Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.向有超高风险发展为精神病的患者开具抗精神病药物处方。
Int Clin Psychopharmacol. 2009 Jul;24(4):223-8. doi: 10.1097/YIC.0b013e32832e0a76.
10
Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.青少年双相精神病的辅助性抗精神病药物治疗。
J Am Acad Child Adolesc Psychiatry. 2001 Dec;40(12):1448-56. doi: 10.1097/00004583-200112000-00016.
引用本文的文献
1
The pharmacological treatment of schizophrenia: How far have we come?精神分裂症的药物治疗：我们取得了多大进展？
PCN Rep. 2022 May 30;1(2):e13. doi: 10.1002/pcn5.13. eCollection 2022 Jun.
2
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.难治性精神分裂症：遗传与神经影像学关联
Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019.
本文引用的文献
1
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.首发精神病患者中药物依从性差及持续使用大麻与复发风险的相关性：一项前瞻性分析。
Lancet Psychiatry. 2017 Aug;4(8):627-633. doi: 10.1016/S2215-0366(17)30233-X. Epub 2017 Jul 10.
2
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.60 年来抗精神病药物治疗急性精神分裂症的安慰剂对照试验：系统评价、贝叶斯荟萃分析和疗效预测因素的荟萃回归。
Am J Psychiatry. 2017 Oct 1;174(10):927-942. doi: 10.1176/appi.ajp.2017.16121358. Epub 2017 May 25.
3
The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.抗精神病药物对精神分裂症临床病程的长期影响。
Am J Psychiatry. 2017 Sep 1;174(9):840-849. doi: 10.1176/appi.ajp.2017.16091016. Epub 2017 May 5.
4
Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.急诊科临床医生对用药情况评估的准确性：临床医生对抗精神病药物使用评估与血浆水平测定的比较
J Clin Psychopharmacol. 2017 Jun;37(3):310-314. doi: 10.1097/JCP.0000000000000697.
5
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.尽管坚持长效注射用抗精神病药物治疗，但与精神分裂症复发相关的因素。
Int Clin Psychopharmacol. 2016 Jul;31(4):202-9. doi: 10.1097/YIC.0000000000000125.
6
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.作为抗精神病药物治疗反应预测指标的纹状体基线功能连接性
Am J Psychiatry. 2016 Jan;173(1):69-77. doi: 10.1176/appi.ajp.2015.14121571. Epub 2015 Aug 28.
7
Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.难治性精神分裂症的神经影像学研究结果：一项系统综述：难治性精神分裂症缺乏神经影像学相关特征。
Schizophr Res. 2015 May;164(1-3):164-75. doi: 10.1016/j.schres.2015.01.043. Epub 2015 Feb 13.
8
A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic).精神分裂症分类的一种神经生物学假说：A型（高多巴胺能型）和B型（正常多巴胺能型）。
Br J Psychiatry. 2014 Jul;205(1):1-3. doi: 10.1192/bjp.bp.113.138578.
9
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.精神障碍患者药物治疗不依从：流行病学、影响因素及管理策略。
World Psychiatry. 2013 Oct;12(3):216-26. doi: 10.1002/wps.20060.
10
Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.缓解期首发精神分裂症患者在早期减药/停药或维持治疗策略的 7 年随访中恢复情况：一项 2 年随机临床试验的长期随访。
JAMA Psychiatry. 2013 Sep;70(9):913-20. doi: 10.1001/jamapsychiatry.2013.19.
Zotero 插件